Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs midazolam for postoperative delirium in elderly hip surgery
ChiCTR2100050511Phase 4Recruiting
- Sponsor
- Beijing Tsinghua Changgung Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in postoperative delirium (POD) (2 arms), sponsored by Beijing Tsinghua Changgung Hospital. Primary endpoint: Incidence of postoperative delirium. Started Sep 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2100050511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050511.